欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2008, Vol. 13 ›› Issue (1): 112-116.

• 临床药理学 • 上一篇    下一篇

酰托普利在健康男、女受试者体内的药代动力学研究

田蕾, 黄一玲, 龚培, 边文彦, 蒋文, 李一石   

  1. 中国医学科学院, 北京协和医学院阜外心血管病医院,卫生部心血管药物临床研究重点实验室, 北京 100037
  • 收稿日期:2007-09-15 修回日期:2007-12-30 出版日期:2008-01-26 发布日期:2020-10-13
  • 通讯作者: 李一石,女, 主任医师, 博士生导师, 主要从事心血管药物临床研究。Tel:010-68331753 E-mail: liyishi@public3.bta.net.cn
  • 作者简介:田蕾, 女, 硕士, 助理研究员, 主要从事新药临床药动学研究。Tel:010-88398547  E-mail:ittl@fuwaihospital.org
  • 基金资助:
    863 国家攻关项目《临床试验关键技术及平台研究》(2002AA2Z341A,2004AA2Z3760)

Pharmacokinetic studies of ceptopril in healthy male and female volunteers

TIAN Lei, HUANG Yi-ling, GONG Pei, BIAN Wen-yan, JIANG Wen, LI Yi-shi   

  1. Key Laboratory of Clinical Trial Research of Cardiovascular Drugs, Ministry of Health, Fuwai Cardiovascular Hospital, CAMS and PUMC, Beijing 100037, China
  • Received:2007-09-15 Revised:2007-12-30 Online:2008-01-26 Published:2020-10-13

摘要: 目的 研究新型血管紧张素转换酶抑制剂酰托普利在健康男、女受试者体内的药代动力学和安全性。方法 10 名健康男、女受试者(男、女各半) 连续口服酰托普利30 mg(bid, 7 d), 另有10名健康男、女受试者(男、女各半) 分别在空腹和进食标准餐后单剂量口服酰托普利60 mg, 按规定时间点取血并测定血浆药物浓度, 采用WinNonlin软件计算药代动力学参数。结果 受试者首次和末次口服30 mg 酰托普利后的平均Cmax 分别为(279±100) 、(299±101) μg L, tmax 分别为(1.2±0.5) 、(1.2±0.3) h, t1 2 分别为(1.3±0.9) 、(1.3±0.5) h, AUC0-t 分别为(421±107) 、(461±152) μg·L-1 ·h, 在二者之间无统计学差异。比较受试者单剂量空腹和餐后口服酰托普利60 mg, tmax明显延后, Cmax有所降低, 其他参数AUC 、t1 2等在两种给药方式间无差异。各试验组中男、女受试者的药动学参数均无统计学差异。结论 本研究未观察到酰托普利有药物蓄积现象, 进食影响该药的吸收速率, 不影响其吸收程度, 其体内过程不受性别差异的影响。

关键词: 酰托普利, HPLC, 药代动力学, 饮食影响

Abstract: AIM: To study the pharmacokinetic profiles of ceptopril, a new ACE inhibitor, in Chinese healthy male and female volunteers. METHODS: 10 healthy volunteers (5 males and 5 females) were en- rolled and 30 mg ceptopril oral dose was given twice daily for 7 days. Another 10 healthy volunteers (5 males and 5 females) were treated with 60mg captopril in the fed and fasted conditions. With the analysis of HPLC for the concentrations of ceptopril in plasma, pharmacokinetic parameters were calculated by Win-Nonlin software. RESULTS: No significant difference was observed between the pharmacokinetic parameters of the 1st dose and the last dose (P >0.05), with values as follows: tmax (1.2±0.5) h and (1.2±0.3)h, Cmax (279±100) μg L and (299±101) μg L, AUC0-t (421±107) μg·L-1 ·h and (461±152)μg·L-1 ·h, t1/2 (1.3±0.9) h and (1.3±0.5) h. Compared with those in fasted condition, tmax was prolonged, and AUC and Cmax were not significantly changed in fed condition. There was no significant difference between the male and female volunteers. CONCLUSION: There was no accumulation when ceptopril was given with multiple doses. Food affected the absorption rate of ceptopril, but did not decrease its exposure. No sex difference was observed.

Key words: ceptopril, HPLC, pharmacokinetics, food effect

中图分类号: